Deleage Jean
SEC-identified person · CIK 1198323 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Talphera, INC. TLPH | Officer | filed 2011 - 2011 |
| Aegerion Pharmaceuticals, Inc. AEGR | Officer | filed 2010 - 2010 |
| Viracta Therapeutics, Inc. VIRX | Officer | filed 2009 - 2010 |
| Rigel Pharmaceuticals INC RIGL | Director | filed 2006 - 2010 |
| Corcept Therapeutics INC CORT | Officer | filed 2007 - 2009 |
| Threshold Pharmaceuticals INC THLDD | Officer | filed 2008 - 2009 |
| Torreypines Therapeutics, Inc. TPTX | Director | filed 2006 - 2009 |
| Kosan Biosciences INC KOSN | Director | filed 2006 - 2008 |
| IDM Pharma, INC. idmi | Director | filed 2006 - 2007 |
| Neurogesx Inc NGSX | Officer | filed 2007 - 2007 |
| Cotherix INC CTRX | Officer | filed 2007 - 2007 |
| Xcyte Therapies INC XYCT | Officer | filed 2006 - 2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.